Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app. The Basel, Switzerland-based company — one of the largest diabetes tech companies in the world — announced the milestone, along with new real-world evidence for its continuous glucose monitoring (CGM) solution, at the European Association […]
Roche
Roche wins CE mark for Susvimo drug-eluting eye implant
Roche announced today that it received CE mark approval for its port delivery platform containing its Susvimo therapeutic. The device, known as Contivue in Europe, comprises the eye implant through which Susvimo is delivered, plus four ancillary devices to initially fill, insert, refill and remove the implant if required. Susvimo (ranibizumab injection) 100 mg/mL remains […]
The 10 largest diabetes technology companies in the world
What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings? We are seeing the industry form an intriguing niche at the intersection of medtech and consumer devices. Various companies around the world are delivering numerous options when it comes to the type of technology they want to […]
Roche, IBM collab on predictive AI for CGM tech
Roche and IBM recently announced the development of an AI-enabled solution to predict glucose levels through continuous glucose monitors (CGMs). Together, the companies developed the AI-based Accu-Chek SmartGuide Predict app. They said in a news release that they launched the solution in Switzerland earlier this year. Roche first unveiled its Accu-Chek SmartGuide in an event at […]
Tandem agrees to pay $36M to settle Roche patent litigation
Tandem Diabetes Care (Nasdaq:TNDM) recently filed an SEC Form 8-K announcing its entry into a patent litigation settlement with Roche. The two companies entered into a settlement, mutual release and cross-license agreement. It resolves all actual or potential patent disputes as of May 21. According to the SEC filing, the settlement relates to Tandem’s t:slim […]
Roche invests $550M to make Indianapolis a CGM manufacturing hub
Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in the U.S. The company plans to invest in its Diagnostics site in Indianapolis in a project that runs through 2030. It expects to make the site — which serves as the North American headquarters […]
The 5 most-read Drug Delivery Business News stories of 2024
There has been no shortage of news across the diabetes and drug delivery markets over the course of 2024. At Drug Delivery Business News, we’ve tried to cover it all. From product launches to major regulatory nods — with significant partnerships and integrations in between — diabetes technology particularly dominated the news over the last 12 […]
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in innovating these technologies (read about those HERE). Those companies have contributed to […]
Glytec, Roche expand diabetes management collaboration
Glytec announced today that it expanded its collaboration with Roche to integrate software with smart diabetes technology. The two companies initially struck a partnership in early 2022. They aimed to combine Glytec’s FDA-cleared Glucommander insulin dosing decision support software with Roche’s expertise in medical devices and IT solutions. It marked an effort to address the […]
Roche wins CE mark for new AI-enabled CGM
Roche announced today that it received CE mark approval for its Accu-Chek SmartGuide continuous glucose monitoring (CGM) system. CE mark approval covers the use of the CGM for people over 18 with type 1 and type 2 diabetes on flexible insulin therapy. The company first unveiled its Accu-Chek SmartGuide in an event at the Advanced […]
